COMPASSIONATE USE Institution Agreement SPECIFICKÝ LÉČEBNÝ PROGRAM SmlouvaCompassionate Use Institution Agreement • February 4th, 2021
Contract Type FiledFebruary 4th, 2021Pre-Approval Access/Compassionate Use of Entrectinib for Patients with Solid Tumors harboring a NTRK Gene Fusion or Patients with Non-Small Cell Lung Cancer (NSCLC) harboring a ROS1 Gene Fusion (AG40852)